Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2008
10/22/2008CN101289442A Novel benzoimidazole derivatives useful as antiproliferative agents
10/22/2008CN101288755A Medicine for treating onychomycosis and
10/22/2008CN101288745A Chinese medicinal composition for treating dehcets disease and preparation method thereof
10/22/2008CN101288738A Production method of medicine for treating vitiligo
10/22/2008CN101288733A Chinese herbal medicine for treating burns
10/22/2008CN101288732A Hair-growing liquid
10/22/2008CN101288685A Medicine for curing burn and scald
10/22/2008CN101288684A Medicine for curing burn and scald
10/22/2008CN101288679A Dissolving and reducing generation method of nano pearl powder
10/22/2008CN101288678A Production method of pearl powder
10/22/2008CN101288672A Medicine for treating dermatopathy and its preparing process
10/22/2008CN101288669A Exterior-applied powder for treating pressure sore
10/22/2008CN101288668A Disinfectant constitutes
10/22/2008CN101288639A Method for purifying pearl hydrolysate using hyperfiltration and nanofiltration
10/22/2008CN101288473A Buthus martensi karsch beauty treatment health-care liquor and extraction method
10/22/2008CN101288472A Preparation method of Buthus martensi karsch beauty treatment health-care wine
10/22/2008CN101288471A Buthus martensi karsch beauty treatment health-care wine
10/22/2008CN100427121C Resina draconis and its total flavone solution preparation and its preparation method
10/22/2008CN100427101C Chilblain preventing and curing cream containing nutria fat
10/22/2008CN100427085C (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/21/2008US7439396 Pharmaceutical/cosmetic compositions comprising novel ligands that activate RAR receptors
10/21/2008US7439393 Phenethanolamine derivatives for treatment of respiratory diseases
10/21/2008US7439362 For treatment of acne, seborrhea, androgenic alopecia. hirsutism, and breast cancer
10/21/2008US7439269 application of moisturizer to nasal cavity may facilitate and/or promote healthy function of the cavity, which in turn may reduce the duration of symptoms associated with a common cold or the flu; comprising: purified water; a hydrophilic thickener; and an encapsulated moisturizing agent
10/21/2008US7439251 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
10/21/2008CA2468847C Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
10/21/2008CA2412708C Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
10/21/2008CA2351947C Hyperforin as cytostatic agent and hyperforin ointment or cream as application form
10/21/2008CA2282345C Pharmaceutical composition
10/21/2008CA2270893C N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity
10/16/2008WO2008124172A1 Combination therapy for chronic dermal ulcers
10/16/2008WO2008123469A1 Six-membered amide compound and use thereof
10/16/2008WO2008123231A1 Novel cyclic staple-type oligonucleotide, and nf-κb decoy comprising the same
10/16/2008WO2008122198A1 Non-steroidal androgen acceptor regulators and their medical use
10/16/2008WO2008089268A3 Methods and compositions for treating conditions associated with infection and/or inflammation
10/16/2008WO2008084171A3 Use of nepafenac or derivatives thereof for treating dermatological disorders linked with a keratinisation disorder that may include an inflammatory immuno-allergic component
10/16/2008WO2008073863A3 Preparation and utility of substituted allylamines
10/16/2008WO2006069329A3 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis
10/16/2008US20080255245 Diphenyl ethene compounds; autoimmune diseases; transplant rejection; rheumatic diseases; multiple sclerosis; antiallergens; skin disorders; chronic obstructive pulmonary disease; anticancer agents; antiischemic agents
10/16/2008US20080255238 Composition containing a thiourea derivative for preventing or treating pruritic or irritant skin diseases
10/16/2008US20080255224 Administering a cannabinoid agonist
10/16/2008US20080255223 Treatment and Prevention of Benign Pigmented Moles (Naevi) Using Artemisinine and the Derivatives Thereof
10/16/2008US20080255191 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/16/2008US20080255186 Pyrazolo[3,4-B]Pyridine Compound, and Its Use as a Pde4 Inhibitor
10/16/2008US20080255168 Methods for administering dpd inhibitors in combination with 5-fu and 5-fu prodrugs
10/16/2008US20080255165 Pharmaceutical Compositions of the Isolated D-Enantiomer of the Quinazolinone Derivative Halofuginone
10/16/2008US20080255163 Compounds such as 2-piperidino-6-methyl-5-oxo-5,6-dihydro-(7H) pyrrole-[3,4-d]pyrimidine maleate (MS-818); nervous system, brain, and neurodegenerative disorders; Parkinson's, Alzheimer's, and Huntington's disease
10/16/2008US20080255160 Mapk/erk kinase inhibitors
10/16/2008US20080255149 1-Oxopiperidine derivatives; amides derived from fused and/or spiro polyheterocycles such as decahydro-(iso)quinoline, tetrahydro(iso)quinoline, piperazine, piperidine, indole, or (iso)indole; histone deacetylase inhibitors; antiproliferative, antitumor, and antitumor agents; hyperplasia; immune diseases
10/16/2008US20080255146 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy
10/16/2008US20080255141 Modulators of signal transduction mediated by certain native and/or mutant tyrosine kinases; antiproliferative, anticarcinogenic, antiallergen, and antiinflammatory agents; metabolic and neurodegenerative disorders
10/16/2008US20080255129 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics
10/16/2008US20080255110 Imidazoquinoline derivatives as adenosine a3 receptor ligands
10/16/2008US20080255082 Hair and/or Scalp Care Compositions Incorporating Terpenoid Compounds
10/16/2008US20080255059 Regulators of the hedgehog pathway, compositions and uses related thereto
10/16/2008US20080255032 Methods and compositions for preventing and treating aging or photodamaged skin
10/16/2008US20080254153 Water Dispersible Composition and Method for Preparing Same
10/16/2008US20080254152 Inhibiting glucocorticoid-induced chronic stress in a dermal cell or a cell involved in skin inflammatory responses
10/16/2008US20080254150 Management of dermatitic symptoms of mammalian integument with emollient disinfectant formulations
10/16/2008US20080254130 Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction
10/16/2008US20080254106 Using antidepressant drug 2,3,3a,4,5,6-hexahydro-8-methyl-1H-pyrazino[3,2,1-jk]carbazole (pirlindole) in combination with other active agents; topical delivery
10/16/2008US20080254105 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
10/16/2008US20080254104 Advanced functional biocompatible polymeric matrix containing nano-compartments
10/16/2008US20080254079 Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology
10/16/2008US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders
10/16/2008US20080254021 Tie1-binding ligands
10/16/2008US20080254019 Therapeutic Agents and Therapeutic Methods For Treating Injured Tissue
10/16/2008US20080254006 Treatment of alopecia by micropore delivery of stem cells
10/16/2008US20080253986 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers
10/16/2008US20080253977 Nucleic acid encoding plant lipase polypeptide isolated from Deschampsia antarctica; host cell from Pichia containing expression vector; genetic engineering; waste water cleaning; sunscreen agents
10/16/2008CA2688736A1 Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology
10/15/2008EP1980256A1 OIL-IN-WATER TYPE EMULSION LOTION CONTAINING 22-OXA-1 alpha ,25-DIHYDROXYVITAMIN D3 AND METHOD OF TREATING SKIN DISEASE BY USING THE SAME
10/15/2008EP1980250A1 Use of mimosine or a derivative thereof for treating the cutaneous effects of psoriasis and related skin disorders, and cosmetic or pharmaceutical composition containing same
10/15/2008EP1980247A1 Growth hormone secretion regulator
10/15/2008EP1978982A2 Use of epoxidised compounds
10/15/2008EP1978827A1 Food supplement based on group b vitamins, trace elements and w-3 and/or w-6 fatty acids and use of this food supplement in the simultaneous treatment of localized cellulite and slackening of the skin
10/15/2008EP1781297B1 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions
10/15/2008EP1776366B1 Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors
10/15/2008EP1660085B1 Pyridylpyrrole derivatives active as kinase inhibitors
10/15/2008EP1471881B1 Use of a compound inactivating the kinase a protein in a composition containing a cosmetically acceptable medium in order to lighten the skin
10/15/2008EP1458723B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/15/2008EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
10/15/2008EP1453798B1 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
10/15/2008EP1444202B1 Novel metalloproteinase inhibitors
10/15/2008EP1383786B1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
10/15/2008EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/15/2008EP1308439B1 Proline derivatives and use thereof as drugs
10/15/2008EP1303600B1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
10/15/2008EP0841946B2 Methods for treatment of allergic asthma
10/15/2008CN201131853Y Chinese prescription absorption cotton pad plate
10/15/2008CN101287759A Methods for treating and preventing fibrosis
10/15/2008CN101287493A Therapy with cd4 binding peptides and radiation
10/15/2008CN101287473A Agent for applying to mucosa and method for production thereof
10/15/2008CN101287457A Use of treprostinil to treat neuropathic diabetic foot ulcers
10/15/2008CN101284808A Compounds and methods for the inhibition of the expression of VCAM-1
10/15/2008CN101284126A Attapulgite kibe chrisma
10/15/2008CN101284125A Attapulgite water-based kibe formulations
10/15/2008CN101284124A Attapulgite alcohol group kibe formulations
10/15/2008CN101284121A Combination medicine for curing the hoary hair
10/15/2008CN101284109A Medicine for curing the burnt, scalded and frostbited corium to regenerate